Background: Anemia is potentially associated with increased morbidity and mortality following vascular surgery procedures. This study investigated whether peri-procedural anemia is associated with reduced 1-year amputation-free survival (AFS) in patients undergoing revascularization for chronic limb-threatening ischemia (CLTI).
Methodology: A retrospective analysis of patients diagnosed with CLTI between February 2018-February 2019, who subsequently underwent revascularization, was conducted. Hemoglobin concentration measured at index assessment was recorded and stratified by WHO criteria. Subsequent peri-procedural red blood cell transfusions (RBC) were also recorded. The primary outcome was 1-year AFS. Kaplan Meier survival analysis and Cox's proportional hazard modelling were conducted to assess the effect of anemia and peri-procedure transfusion on outcomes.
Results: 283 patients were analyzed, of which 148 (52.3%) were anemic. 53 patients (18.7%) underwent RBC transfusion. Patients with anemia had a significantly lower 1-year AFS (64.2% vs. 78.5%, P = 0.009). A significant difference in 1-year AFS was also observed based upon anemia severity (P = 0.008) and for patients who received RBC transfusion (45.3% vs 77.0%, P < 0.001). On multivariable analysis, moderately severe anemia was independently associated with increased risk of major amputation/death (aHR 1.90, 95% CI 1.06-3.38, P = 0.030). After adjusting for severity of baseline anemia, peri-procedural RBC transfusion was associated with a significant increase in the combined risk of major amputation/death (aHR 3.15, 95% CI 1.91-5.20, P < 0.001).
Conclusion: Moderately severe peri-procedural anemia and subsequent RBC transfusion are independently associated with reduced 1-year AFS in patients undergoing revascularization for CLTI. Future work should focus on investigating alternative measures to managing anemia in this cohort.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.avsg.2021.07.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Outcomes of prophylactic fasciotomy in patients with non-traumatic acute limb ischemia.
Vascular
December 2024
Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Article Synopsis
- * Data from 356 patients were analyzed, revealing that the 30-day amputation rates were comparable between PF (12.5%) and NPF (10%) groups, but PF patients had significantly lower overall survival rates within 30 days and long-term (1 and 5 years) compared to NPF.
- * Additionally, wound infection rates were higher in the PF group (5.5%) than in the NPF group (1.7%), suggesting
One-year clinical outcomes of endovascular revascularization in patients with acute limb ischemia.
Heart Vessels
December 2024
Department of Cardiovascular Medicine, Asahi General Hospital, I-1326 Asahi, Chiba, 289-2511, Japan.
Urgent revascularization should be performed to patients with acute limb ischemia (ALI) unless the ischemia is irreversible. In patients with severe ALI and multiple morbidities, surgical revascularization is not feasible; however, endovascular revascularization (EVR) may be an option. This study aimed to examine 1-year clinical outcomes of EVR in patients with ALI and determine prognostic factors.
View Article and Find Full Text PDFImportance of Successful Revascularization in Acute Limb Ischemia: Sub-Analysis From the RESCUE ALI Trial.
Catheter Cardiovasc Interv
December 2024
Department of Vascular Surgery, Asahikawa Medical University, Asahikawa, Japan.
Background: This study aimed to assess the 1-year clinical outcomes and predictors of technical success in acute limb ischemia (ALI) treatment.
Methods: A sub-analysis of the REtroSpective multiCenter study of endovascUlar or surgical intErvention for ALI (RESCUE ALI) study involved 185 patients with ALI and technical success (n = 131) or failure (n = 54) treated via surgical, endovascular, or hybrid revascularization between January 2015 and August 2021. The primary endpoint was 1-year amputation-free survival (AFS), and the secondary endpoints included preoperative complications and 1-year reintervention.
The Untold Story: Early and Mid-Term Results of Subintimal Angioplasty in Superficial Femoral Artery Versus Popliteal Artery Chronic Total Occlusion.
J Endovasc Ther
September 2024
Department of Vascular and Endovascular Surgery, Faculty of Medicine, Assiut University Hospital, Assiut University, Assiut, Egypt.
Objectives: This study aims to compare the immediate and mid-term outcomes of subintimal angioplasty (SIA) of chronic total occlusions (CTOs) of superficial femoral artery (SFA) versus popliteal artery (PA) and to identify possible predictors of loss of limb-based patency (LBP).
Methods: This is a retrospective analysis of chronic lower-limb ischemia (CLI) patients (Rutherford classes 3-6) presenting with CTO of SFA or PA treated by SIA and selective stenting in the period 2018 to 2021. Immediate outcomes were compared between the SFA and PA groups, including technical success, perioperative complications, and 30-day major amputation and mortality rates.
Outcomes of a Multidisciplinary Vascular Practice: 12-Month Amputation-Free Survival and Beyond in Patients With Chronic Limb-Threatening Ischemia.
J Endovasc Ther
September 2024
The Vascular Institute, Atlantic Medical Imaging, Galloway, NJ, USA.
Article Synopsis
- * Methods: A retrospective analysis was conducted on patients with Rutherford stages 4, 5, and 6, examining factors like lesion complexity and amputation rates while collaborating with a multidisciplinary team for complex cases.
- * Results: The study involved 829 limbs, revealing a one-year mortality rate of 6.2%, major amputation rate of 2.3%, and a 78.7% success rate for clinically driven target lesion revascularization, indicating the efficacy of newer stent technologies in reducing the need for reinterventions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!